glp 1 pancreatic cancer risk Frontiers Glucagon-like peptide 1 receptor agonists
Description
Why GLP-1 Weight Loss Plateaus Happen Weight loss plateaus happen for a variety of physiological reasons
Y.et al (2016)
Limitations and future perspective The use of GLP-1RAs is predicted to increase in treating diabetes, neurological disorders, and IBD
Drp1-mediated mitochondrial abnormalities link to synaptic injury in diabetes model
For example, at the time of the study, of those using GLP - 1 drugs for longer than one year, more than three-quarters said they were using the drug for health management, and less than one-quarter for weight loss
